CytoSorb Shipment Arrives in Designated Mainland China Hospitals to Treat Cytokine Storm in Critically-ill Patients with COVID-19 Coronavirus Infection
- Friday, February 28, 2020, 7:04
- Finance
- Add a comment
MONMOUTH JUNCTION, N.J., Feb. 28, 2020 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader with more than 80,000 global treatments of its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery…
About the Author
adminasapcorp has written 38957 stories on this site.